Outset Medical (OM) EBITDA Margin Growth (3y) (2022 - 2026)
Analysis
Outset Medical (OM) EBITDA Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.05 Bn | 174.44 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.97 Bn | 122.75 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.27 Bn | 108.45 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 103.98 Bn | 100.50 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.03 Bn | 62.49 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 32.93 Bn | 31.47 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.26 Bn | 30.31 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 244.00 |
| 10 | Outset Medical | 59.95 Mn | -203.24 Mn | 13.28 Mn | 7,109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,109.00 |
| Mar 31, 2026 | 6,921.00 |
| Dec 31, 2025 | 6,337.00 |
| Sep 30, 2025 | 9,396.00 |
| Jun 30, 2025 | 12,081.00 |
| Mar 31, 2025 | 6,428.00 |
| Dec 31, 2024 | 7,074.00 |
| Sep 30, 2024 | 3,135.00 |
| Jun 30, 2024 | 627.00 |
| Mar 31, 2024 | -154.00 |
| Dec 31, 2023 | 6,087.00 |
| Sep 30, 2023 | 14,640.00 |
| Jun 30, 2023 | 9,150.00 |
| Mar 31, 2023 | 15,115.00 |
| Dec 31, 2022 | 13,768.00 |
| Sep 30, 2022 | 55,384.00 |
| Jun 30, 2022 | 69,797.00 |
| Mar 31, 2022 | 85,580.00 |